New eye drop treatment seeks to soothe millions with dry eyes
NCT ID NCT06780306
Summary
This study tested a new treatment called TTAX03 for people with mild to moderate dry eye disease. Researchers compared three different doses of TTAX03 against a simple saline solution to see which was safest and most effective at reducing symptoms and healing eye damage. The treatment was applied using a special contact lens worn for five days, and participants were followed for twelve weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research, LLC.
Deerfield Beach, Florida, 33064, United States
-
CORE, Inc. / Vita Eye Clinic
Shelby, North Carolina, 28150, United States
-
Eye Associates of North Jersey
Dover, New Jersey, 07801, United States
-
Northern New Jersey Eye Institute
South Orange, New Jersey, 07079, United States
-
Southwest Eye Care
Chaska, Minnesota, 55318, United States
-
University California Berkeley
Berkeley, California, 94720, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Westlake Eye Specialists
Austin, Texas, 78749, United States
-
Wilmington Eye at Brunswick Forest
Leland, North Carolina, 28451, United States
Conditions
Explore the condition pages connected to this study.